80 results on '"Glasser, Stephen P"'
Search Results
2. What is the association of lipid levels and incident stroke?
3. Prevalence of electrocardiographic abnormalities based on hypertension severity and blood pressure levels: the Reasons for Geographic and Racial Differences in Stroke study
4. Gender, race, age, and regional differences in the association of pulse pressure with atrial fibrillation: the Reasons for Geographic and Racial Differences in Stroke study
5. Is there an association between the prevalence of atrial fibrillation and severity and control of hypertension? The REasons for Geographic And Racial Differences in Stroke study
6. Statin therapy and plasma coenzyme Q10 concentrations—A systematic review and meta-analysis of placebo-controlled trials
7. Race–Sex Differences in the Management of Hyperlipidemia: The REasons for Geographic And Racial Differences in Stroke Study
8. Effects of Coenzyme Q10 on Statin-Induced Myopathy: A Meta-analysis of Randomized Controlled Trials
9. Objective sleep, a novel risk factor for alterations in kidney function: the CARDIA study
10. Declines in coronary heart disease incidence and mortality among middle-aged adults with and without diabetes
11. Statin Underuse and Low Prevalence of LDL-C Control Among U.S. Adults at High Risk of Coronary Heart Disease
12. Primary Prophylactic Aspirin Use and Incident Stroke: Reasons for Geographic and Racial Differences in Stroke Study
13. Both morning and evening dosing of nebivolol reduces trough mean blood pressure surge in hypertensive patients
14. Smoking, inflammatory patterns and postprandial hypertriglyceridemia
15. Does differential prophylactic aspirin use contribute to racial and geographic disparities in stroke and coronary heart disease (CHD)?
16. Pharmacogenetics of antihypertensive treatment
17. Efficacy and safety of a once-daily graded-release diltiazem formulation dosed at bedtime compared to placebo and to morning dosing in chronic stable angina pectoris
18. Reduced small artery but not large artery elasticity is an independent risk marker for cardiovascular events
19. Efficacy and safety of a once daily graded-release diltiazem formulation in essential hypertension
20. Blood pressure and arterial compliance in young adults: the Minnesota Children’s Blood Pressure Study
21. Arterial compliance abnormalities in isolated systolic hypertension
22. Secular changes in rates of coronary heart disease, fatal coronary heart disease, and out-of-hospital fatal coronary heart disease
23. Orthostatic systolic blood pressure changes in SPRINT participants at baseline
24. The association of pulse pressure with atrial fibrillation
25. Health Knowledge About Symptoms of Heart Attack and Stroke in Adult Survivors of Childhood Acute Lymphoblastic Leukemia
26. Effect of doxazosin on arterial elasticity: functional versus structural changes
27. Efficacy and safety of diltiazem HCl extended release (G99) dosed at nighttime (10PM) compared to placebo and to morning dosing (8AM) in moderate to severe essential hypertension
28. Prospects for therapy of nitrate tolerance
29. Vascular Compliance and Cardiovascular Disease: A Risk Factor or a Marker?
30. The efficacy and safety of once-daily nifedipine administered without food: the coat-core formulation compared with the gastrointestinal therapeutic system formulation in patients with mild-to-moderate hypertension
31. The efficacy and safety of once-daily nifedipine: the coat-core formulation compared with the gastrointestinal therapeutic system formulation in patients with mild-to-moderate diastolic hypertension
32. Three Unusual Complications Resulting from Attempted Repair of Partial Anomalous Pulmonary Venous Drainage
33. Chloral Hydrate Overdose and Cardiac Arrhythmias
34. Occurrence of Frequent Complex Arrhythmias Detected by Ambulatory Monitoring: Findings in an Apparently Healthy Asymptomatic Elderly Population
35. Arrhythmias Detected by Ambulatory Monitoring: Lack of Correlation With Symptoms of Dizziness and Syncope
36. Clinical Mechanisms of Nitrate Action
37. Effect of Extended-Release Isosorbide Mononitrate One Hour After Dosing in Patients With Stable Angina Pectoris
38. Effects of zatebradine (ULFS 49 CL), a sinus node inhibitor, on heart rate and exercise duration in chronic stable angina pectoris
39. The arrhythmogenic effect of static electricity on the dog heart
40. Hypertension, hypertrophy, hormones, and the heart
41. The placebo effect in cardiovascular disease
42. Atherosclerosis: Risk factors and the vascular endothelium
43. Effect of intravenous isosorbide dinitrate versus nitroglycerin on elevated pulmonary arterial wedge pressure during acute myocardial infarction
44. Efficacy and safety of extended-release isosorbide mononitrate for stable effort angina pectoris
45. Clinical safety and efficacy of once-a-day amlodipine for chronic stable angina pectoris
46. Safety and compatibility of betaxolol hydrochloride combined with diltiazem or nifedipine therapy in stable angina pectoris
47. Effects of dilevalol, metoprolol and atenolol on left ventricular mass and function in nonelderly and elderly hypertensive patients
48. Influence of beta 2 agonism and beta 1 and beta 2 antagonism on adverse effects and plasma lipoproteins: Results of a multicenter comparison of dilevalol and metoprolol
49. Antianginal and anti-ischemic efficacy of immediate-release nisoldipine in chronic stable angina pectoris
50. Comparison of the antiarrhythmic effects of acebutolol and propranolol in the treatment of ventricular arrhythmias
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.